« Previous Next »European Journal of Cancer
Volume 46, Issue 2 , Pages 420-429, January 2010

Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma

Michele Moschetta
- Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Italy
Giulia Di Pietro
- Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Italy
Roberto Ria
- Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Italy
Antonio Gnoni
- Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Italy
Giuseppe Mangialardi
- Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Italy
Attilio Guarini
- Hematology Unit, Institute of Oncology ‘Giovanni Paolo II’, I-70100 Bari, Italy
Paolo Ditonno
- Hematology Unit, ‘Di Venere’ Hospital, I-74100 Bari, Italy
Pellegrino Musto
- Hematology and Bone Marrow Transplantation Unit, Centro di Riferimento Oncologico della Basilicata IRCCS-CROB, I-85028 Rionero in Vulture, Potenza, Italy
Fiorella D’Auria
- Hematology and Bone Marrow Transplantation Unit, Centro di Riferimento Oncologico della Basilicata IRCCS-CROB, I-85028 Rionero in Vulture, Potenza, Italy
Maria Rosaria Ricciardi
- Division of Hematology, Department of Cellular Biotechnologies and Hematology, University ‘La Sapienza’, I-00100 Rome, Italy
Franco Dammacco
- Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Italy
Domenico Ribatti
- Department of Human Anatomy and Histology, University of Bari Medical School, Italy
Angelo Vacca
- Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Italy
- Corresponding author: Department of Internal Medicine and Clinical Oncology, Policlinico – Piazza Giulio Cesare, 11, I-70124 Bari, Italy. Tel.: +39 080 559 34 44; fax: +39 080 559 21 89.